US Map / North Dakota
State ND

Clinical Trials in North Dakota

North Dakota is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in North Dakota and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 37 actively recruiting studies with North Dakota sites out of 37 registered in total. The busiest research areas in North Dakota are Stage IVB Prostate Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Anatomic Stage II Breast Cancer AJCC v8. Leading sponsors running trials in the state include National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, Children's Oncology Group. By stage, North Dakota trials break down as Phase 1 (1), Phase 2 (11), Phase 3 (24), Phase 4 (1).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
37
Recruiting Now
37
← Back to US Map
Top Conditions in North Dakota
Stage IVB Prostate Cancer AJCC v8 (2)Lung Non-Small Cell Carcinoma (2)Anatomic Stage II Breast Cancer AJCC v8 (2)Neovascular Age-related Macular Degeneration (1)HPV-unrelated Head and Neck Squamous Cell Carcinoma (1)Metastatic Castration-Resistant Prostate Carcinoma (1)Metastatic Prostate Adenocarcinoma (1)Recurrent Head and Neck Squamous Cell Carcinoma (1)Recurrent Hypopharyngeal Squamous Cell Carcinoma (1)Recurrent Laryngeal Squamous Cell Carcinoma (1)Recurrent Oral Cavity Squamous Cell Carcinoma (1)Recurrent Oropharyngeal Squamous Cell Carcinoma (1)

Frequently Asked Questions — Clinical Trials in North Dakota

How many clinical trials are currently recruiting in North Dakota?
ClinicalMetric currently tracks 37 actively recruiting clinical trials with at least one location in North Dakota. The total number of registered studies—including active but not currently enrolling trials—is 37. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in North Dakota?
North Dakota hosts clinical trials across a broad range of medical conditions, including Stage IVB Prostate Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Anatomic Stage II Breast Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout North Dakota serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in North Dakota?
To join a clinical trial in North Dakota, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in North Dakota maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in North Dakota

NCT05896189 N/A
Recruiting
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Surv...
Condition
Breast Cancer
Enrollment
386 pts
Location
United States, Puerto Rico
Sponsor
NRG Oncology
View Trial →
NCT07321652 Phase 3
Recruiting
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment ...
Condition
Chronic Lymphocytic Leukemia
Enrollment
466 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT06008561 N/A
Recruiting
Midwest Birth Outcomes and Indigenous American Pregnancy
Condition
Pregnancy
Enrollment
80 pts
Location
United States
Sponsor
Sanford Health
View Trial →
NCT02523014 Phase 2
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating ...
Condition
Intracranial Meningioma
Enrollment
124 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT04402788 Phase 2, Phase 3
Recruiting
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment ...
Condition
Extensive Stage Lung Small Cell Carcinoma
Enrollment
138 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04322318 Phase 2
Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and R...
Condition
Anaplastic Kidney Wilms Tumor
Enrollment
256 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT06293053 Phase 3
Recruiting
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participa...
Condition
Prurigo Nodularis
Enrollment
18 pts
Location
United States
Sponsor
Sanofi
View Trial →
NCT04804644 Phase 3
Recruiting
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Who...
Condition
Metastatic Lung Small Cell Carcinoma
Enrollment
200 pts
Location
United States, Canada
Sponsor
NRG Oncology
View Trial →
NCT06058377 Phase 3
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy T...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
3,680 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04267848 Phase 3
Recruiting
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemoth...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
1,210 pts
Location
United States, Guam
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06876714 Phase 3
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People W...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
1,524 pts
Location
United States, Puerto Rico
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT03851445 Phase 2, Phase 3
Recruiting
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung...
Condition
Previously Treated Non-Small Cell Lung Cancer
Enrollment
10,000 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
Page 2 of 2 — 37 trials total
← Prev
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology